A phase 3 study to assess the immunogenicity, safety, and tolerability of MenB-FHbp administered as a 2-dose schedule in adolescents and young adults-Reference-Cited by-同舟云学术

A phase 3 study to assess the immunogenicity, safety, and tolerability of MenB-FHbp administered as a 2-dose schedule in adolescents and young adults

Published:2022-01 Issue:2 Volume:40 Page:351-358
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Drazan Daniel,Czajka Hanna,Maguire Jason D.,Pregaldien Jean-Louis,Maansson Roger,O'Neill Robert,Anderson Annaliesa S,Balmer Paul,Beeslaar Johannes,Perez John L

Funder

Pfizer Inc Boulder

Pfizer

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference32 articles.

1. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP);Cohn;MMWR Recomm Rep,2013

2. Meningococcal carriage by age: a systematic review and meta-analysis;Christensen;Lancet Infect Dis,2010

3. Centers for Disease Control and Prevention. Enhanced Meningococcal Disease Surveillance Report, 2017, https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report-2017.pdf; 2017 [accessed July 2, 2020].

4. European Centre for Disease Prevention and Control. Invasive Meningococcal Disease: Annual Epidemiological Report for 2017, https://ecdc.europa.eu/sites/portal/files/documents/AER_for_2017-invasive-meningococcal-disease.pdf; 2017 [accessed August 10, 2020].

5. Clinical recognition of meningococcal disease in children and adolescents;Thompson;Lancet,2006

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Escherichia coli in the production of biopharmaceuticals;Biotechnology and Applied Biochemistry;2024-09-08

2. Immunogenicity and safety of a pentavalent meningococcal ABCWY vaccine in adolescents and young adults: an observer-blind, active-controlled, randomised trial;The Lancet Infectious Diseases;2023-12

3. Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review;Infectious Diseases and Therapy;2023-07-06

4. Healthy Vaccinee Bias and MenB-FHbp Vaccine Effectiveness Against Gonorrhea;Sexually Transmitted Diseases;2023-03-02

5. Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults;Human Vaccines & Immunotherapeutics;2023-01-02